Please assess the completion status of the following clinical trial:

Trial Title: Impact of Reduction of Dust Mite Allergenic Load on Step Down of Inhaled Corticosteroids in Stable Asthma

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* confirmed asthma diagnosis~* controlled asthma for more than 3 months~* treatment with inhaled corticosteroids~* dust mite allergy proved by skin tests ou specific immunoglobulin E~Exclusion Criteria:~* chronic obstructive pulmonary disease, bronchiectasis, Fibrosis, tuberculosis~* asthma-chronic obstructive pulmonary disease overlap syndrome~* ongoing desensitization for dust mite~* pregnancy~* previous use of Acar'up

- Gender: ALL
- Minimum Age: 16 Years
- Maximum Age: 100 Years
- Healthy Volunteers: f

Study Arms:
- control group (Type: PLACEBO_COMPARATOR): stable asthmatics receiving an Acar'up placebo system
- treatment group (Type: ACTIVE_COMPARATOR): stable asthmatics receiving Acar'up system

Based on this trial design, predict the completion outcome and termination type (if applicable).